Pharmacy

Introducing generic competition to the market has long been cited as a way to lower drug prices in the U.S.

OxyContin maker Purdue Pharma is considering filing for bankruptcy — a move that could complicate the legal battle over who's responsible for the opioid crisis, according to a STAT news report.

More than 100 value-based contracts were reached between payers and drug manufacturers between 2014 and 2017, suggesting that these contracts may be more prevalent than expected, according to a recent study published in the American Journal of Managed Care.

Hospital drug spending jumped 18.5 percent between 2015 and 2017, a rate which generated about $1.8 million in new costs for the average hospital. This comes on top of a 38 percent increase in inpatient drug spending per admission that…

Pharma giant Novartis agreed to pay $23 million to settle allegations that it used charities to pay kickbacks to Medicare patients to cover their out-of-pocket costs, according to a STAT news report.

After piloting audiology services for several years, CVS has decided to close its 30 U.S. hearing centers, according to CNBC.

Twenty-nine percent of patients reported not taking their medication as prescribed in the last year because of cost, according to a new poll released by the Kaiser Family Foundation.

Pharmaceutical companies have been taking advantage of patients and healthcare providers by hiking the prices of the drugs they rely on, American Hospital Association CEO Richard Pollack wrote in an opinion piece March 1.

Purdue Pharma is considering filing for bankruptcy to protect the company from significant liabilities that may arise from thousands of lawsuits claiming the OxyContin maker contributed to the nationwide opioid epidemic, Reuters reports.

Eli Lilly will offer a lower-priced authorized generic version of its insulin drug Humalog as drugmakers face pressure to rein in the costs of medications.